Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio 
U.S. Stock Futures Mixed as Tech and AI Stocks Face Pressure Ahead of CPI Data 
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 
Gold and Silver Prices Dip as Markets Await Key U.S. Economic Data 
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
Japan PMI Data Signals Manufacturing Stabilization as Services Continue to Drive Growth 
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs 
Global Markets Slide as Tech Stocks Sink, Yields Rise, and AI Concerns Deepen 
Russia Stocks End Flat as Energy and Retail Shares Show Mixed Performance 
Oil Prices Rebound as U.S.-Venezuela Tensions Offset Oversupply Concerns 
Dollar Struggles as Markets Eye Key Central Bank Decisions and Global Rate Outlooks 
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff 
Fed Near Neutral Signals Caution Ahead, Shifting Focus to Fixed Income in 2026 
Roche will be making big changes in the organization of its employees, which is estimated to be around 100,000 in number. The company is taking this step as it implements new prioritization of the works.
Announcement of change in the workforce
As part of the plans, Roche will be eliminating 300 to 400 jobs this year. The affected employees will be the ones working at the company’s product development sites.
According to Reuters, the news about job cuts was announced by Levi Garraway, the firm’s chief medical officer. Through a video call with the employees, he directly told them what the company is planning to do.
"We have made the difficult decision to reduce our workforce in PD by around five to seven percent by the end of the year," he said. "And that equates to somewhere between 300 to 400 roles that will be impacted globally."
The company knows that this is a big blow to the affected workers, so Roche will try to lessen the impact by working with employees. It was not mentioned, though, how the company intends to help those who are about to lose their position.
Who are set to lose their jobs
Based on the information shared, the Roche employees that will be cut from the company are those who are in the product development units and working in the area of project management, business management, administrative support, project delivery, managers, and posts in learning and development.
The product development sites that will cut workers are located in Canada, Britain, United States, Switzerland, and China. Those who will be laid off are set to be notified between the months of August and October, and British employees are the first ones to go.
Felix Arellano, Roche’s head of global drug safety, admitted that this is the hardest thing that he had to do since he started working for the company. He was referring to the fact that he has to send off colleagues as they have been eliminated by the company, as per Fierce Biotech.
Finally, while Roche is cutting jobs, some of the other major pharmaceutical companies are looking for more workers. Most are building new factories, so they need to hire hundreds of workers.
